4. Abstracts will be published exactly as submitted. No editing of abstract texts will be done. However, non-adherence to the above guidelines may be corrected (e.g. use of drug names, keywords) by the meeting organizers.
5. After submission, abstracts cannot be changed by the authors anymore. Should minor changes be necessary after submission, the submitting author should notify the ITO-2012 Secretariat by email, describing exactly the nature of the change to be made. The ITO-2012 organizers will then implement the change. In case of major changes, the authors should submit a revised abstract as an entirely new abstract and request the ITO-2012 Secretariat to delete the original abstract. The addition of a co-author constitutes a major change.
6. After completion of the abstract review, the submitting author will receive scheduling information via email. Abstracts cannot be withdrawn after receipt of the scheduling information by the submitting author. The presenting author must be registered as ITO-2012 participant for final scheduling and publication of the abstract.
7. Accepted abstracts will be published in the Congress Proceedings. The authors of the submitted abstracts will take responsibilities of any Intellectual Property issues about the abstracts on their own. The organizing committee of ITO-2012 has the legal rights to use the submitted abstracts for conference purpose.